Cardiovascular and metabolic phenotypes in relation to the ADRA2B insertion/deletion polymorphism in a Chinese population

Journal of Hypertension

Volumn 23, Issue 12, 2005, Pages 2201-2207

  Zhang, Haifeng ^a   Li, Xinli ^a   Huang, Jun ^a   Li, Yan ^b   Thijs, Lutgarde ^c   Wang, Zhenzhen ^a   Lu, Xinzheng ^a   Cao, Kejiang ^a   Xie, Sifeng ^d   Staessen, Jan A ^c,e   Wang, Ji Guang ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^d Taicang 2nd Hospital   (China)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ADRA2B; Adrenergic receptor; Blood pressure; Gene; Metabolic syndrome; Obesity

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR ALPHA2B; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; COVARIANCE; DIASTOLIC BLOOD PRESSURE; FAMILY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC RISK; HETEROZYGOTE; HETEROZYGOTE DETECTION; HOMEOSTASIS; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLISM; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 27944458877     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000189869.48290.91     Document Type: Article

References (34)

1. Gavras I, Manolis AJ, Gavras H. The α2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies. J Hypertens 2001; 19:2115-2124.
2. Gavras I, Gavras H. Role of α2-adrenergic receptors in hypertension. Am J Hypertens 2001; 14:171S-177S.
3. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, et al. Cardiovascular regulation in mice lacking α2-adrenergic receptor subtypes b and c. Science 1996; 273:803-805.
4. Makaritsis KP, Handy DE, Johns C, Kobilka B, Gavras I, Gavras H. Role of the α2B-adrenergic receptor in the development of salt induced hypertension. Hypertension 1999; 33:14-17.
5. Kintsurashvili E, Gavras I, Johns C, Gavras H. Effects of antisense oligodeoxynucleotide targeting of the α2B-adrenergic receptor messenger RNA in the central nervous system. Hypertension 2001; 38:1075-1080.
6. Kintsurashvili E, Johns C, Ignjacev I, Gavras I, Gavras H. Central α2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertension. J Hypertens 2003; 21:961-967.
7. Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc Natl Acad Sci USA 1988; 85:6301-6305.
8. Heinonen P, Koulu M, Pesonen U, Karvonen MK, Rissanen A, Laakso M, et al. Identification of a three-amino acid deletion in the α2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab 1999; 84:2429-2433.
9. Baldwin CT, Schwartz F, Baima J, Burzstyn M, DeStefano AL, Gavras I, et al. Identification of a polymorphic glutamic acid stretch in the α2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens 1999; 12:853-857.
10. Small KM, Brown KM, Forbes SL, Liggett SB. Polymorphic deletion of three intracellular acidic residues of the α2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 2001; 276:4917-4922.
11. Sivenius K, Lindi V, Niskanen L, Laakso M, Uusitupa M. Effect of a three-amino acid deletion in the α2B-adrengergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord 2001; 25:1609-1614.
12. Sivenius K, Niskanen L, Laakso M, Uusitupa M. A deletion in the α2B-adrenergic receptor gene and autonomic nervous function in central obesity. Obes Res 2003; 11:962-970.
13. Snapir A, Scheinin M, Groop LC, Orho-Melander M. The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type-2 diabetes. Cardiovasc Diabetol 2003; 24:15 (doi: 10.1186/1475-2840-2-15; accessed on 10 July 2005).
14. von Wowern F, Bengtsson K, Lindblad U, Rastam L, Melander O. Functional variant in the α-2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension 2004; 43:592-597.
15. Siitonen N, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Association between a deletion/insertion polymorphism in the α2B-adrenergic receptor gene and insulin secretion and type-2 diabetes. The Finnish diabetes prevention study. Diabetologia 2004; 47:1416-1424.
16. Snapir A, Heinonen P, Tuomainen TP, Alhopuro P, Karvonen MK, Lakka TA, et al. An insertion/deletion polymorphism in the α2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 2001; 37:1516-1522.
17. Snapir A, Mikkelsson J, Perola M, Penttila A, Scheinin M, Karhunen PJ. Variation in the α2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J Am Coll Cardiol 2003; 41:190-194.
18. Suzuki N, Matsunaga T, Nagasumi K, Yamamura T, Shihara N, Moritani T, et al. α2B-adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese. J Clin Endocrinol Metab 2003; 88:1184-1187.
19. Li X, Zhang H, Huang J, Xie S, Zhu J, Jiang S, et al. Gender-specific association between pulse pressure and C-reactive protein in a Chinese population. J Hum Hypertens 2005; 19:293-299.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
21. Abecasis GR, Cardon LR, Cookson WC. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66:279-292.
22. Waldman ID, Robinson BF, Rowe DC. A logistic regression based extension of the TDT for continuous and categorical traits. Am Hum Genet 1999; 63:329-340.
23. Etzel JP, Rana BK, Wen G, Parmer RJ, Schork NJ, O'Connor DT, et al. Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension 2005; 45:1207-1213.
24. Gong G, Dobin A, McArdle S, Sun L, Johnson ML, Pettinger WA. Sex influence on renal α2-adrenergic receptor density in the spontaneously hypertensive rat. Hypertension 1994; 23:607-612.
25. Gong G, Dobin A, Johnson ML, Pettinger WA. Sexual dimorphism of renal α2-adrenergic receptor regulation in Dahl rats. Hypertens Res 1996; 19:83-89.
26. Coatmellec-Taglioni G, Dausse JP, Giudicelli Y, Ribiere C. Gender difference in diet-induced obesity hypertension: implication of renal α2-adrenergic receptors. Am J Hypertens 2002; 15:143-149.
27. Gong G, Johnson ML, Pettinger WA. Testosterone regulation of renal α2B-adrenergic receptor mRNA levels. Hypertension 1995; 25:350-355.
28. Khalid M, Ilhami N, Giudicelli Y, Dausse JP. Testosterone dependence of salt-induced hypertension in Sabra rats and role of renal α2-adrenoceptor subtypes. J Pharmacol Exp Ther 2002; 300:43-49.
29. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1:43-46.
30. Zhou B, Wu Y, Yang J, Li Y, Zhang H, Zhao L. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes Rev 2002; 3:147-156.
31. Wu Y, Zhou B, Tao S, Wu X, Yang J, Li Y, et al. Prevalence of overweight and obesity in Chinese middle-aged populations: current status and trend of development [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2002; 23:11-15.
32. Li G, Chen X, Jang Y, Wang J, Xing X, Yang W, et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes Rev 2002; 3:167-172.
33. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 1996; 93:1372-1379.
34. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162:1867-1872.